Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
UK to commence anti-TB BCG vaccine trials to test efficacy against COVID-19
Previous studies suggest that the BCG vaccine could reduce susceptibility to a range of infections caused by viruses including…
Sun Pharma, Strides Pharma recall drugs in the US
Sun Pharma is recalling 747 bottles of generic diabetes drug due to higher levels of NDMA while Strides Pharma is recalling 11,280…
Occupational hazard, exposure risk are key factors for prioritising COVID-19 vaccine: Dr Vardhan
Adequate safety and efficacy data is required for emergency use authorization vaccine approval for ensuring patient safety, he…
Bristol Myers Squibb presents data from True North trial of Zeposia (ozanimod) for ulcerative…
Both primary and all key secondary efficacy endpoints showed statistically significant improvements with oral Zeposia versus…
Mexico pays nearly $160 mn for COVAX vaccine plan
The latest payment will allow Mexico to acquire enough doses of a vaccine to immunise up to a fifth of the country’s population of…
US FDA issues warning letter to Shilpa Medicare for Jadcherla facility, Telangana
The company believes that the warning letter will have minimum impact of disruption of supplies and the existing revenues from…
Mental health drugs market: Assessing the growth potential
Philippa Salter, Healthcare Analyst, GlobalData points out that any novel therapies and drugs that can tackle treatment-resistant…
Bharat Biotech told to provide phase II data of Covaxin before phase III trial
The SEC also observed that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported so…
US, AstraZeneca sign pact for COVID-19 antibody treatment used to treat Trump
The agreement, under Operation Warp Speed, is to develop a monoclonal antibody cocktail that can prevent COVID-19, especially in…
Deal value in the M&A market decreased in Sept 2020 compared to $35.7 bn in Aug 2020
In September 2020, the healthcare industry reported 84 deals worth $28.2 billion as compared to the last 12-month average…